NCT05083169 2026-05-08MajesTEC-3Janssen Research & Development, LLCPhase 3 Active not recruiting587 enrolled 1 FDA
NCT03180736 2025-12-19EMN14European Myeloma Network B.V.Phase 3 Completed304 enrolled 19 charts 1 FDA